The Natus Medical Inc. board authorized the repurchase of up to $30 million of the company's common shares.
The Pleasanton, Calif.-based healthcare distributor will use cash on hand, cash generated from operations, as well as existing credit facilities or other financing to fund the transaction.
As of Dec. 31, 2017, the company had cash and cash equivalents of approximately $89 million and availability under an existing line of credit of $70 million.
The share repurchase program is set to expire Feb. 26, 2019.
